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Title: Activity of Atypical Protein Kinase C: From Regulation to Substrate Localization 
 
 
 The phosphorylation activity of protein kinases is involved in virtually all 
biological processes of living organisms. As uncontr lled kinase cascades cause 
devastating defects such as cancer, cells employ complex regulatory networks to 
precisely control their activity. Atypical Protein Kinase C (aPKC) is a well-conserved 
protein kinase that plays a central role in the establishment of the Par complex-mediated 
cell polarity. The goal of my research is to understand how aPKC activity is regulated 
and how aPKC phosphorylates its substrates. The first part of my study focused on the 
mechanism by which intra- and intermolecular interactions regulate aPKC activity. aPKC 
contains a pseudosubstrate domain that acts as an inter al inhibitor. Despite the presence 
of the cis-acting inhibitor, another Par complex memb r, Par-6, is thought to repress 
aPKC activity. To examine the precise mechanism by which the pseudosubstrate domain 
and Par-6 regulate aPKC activity, I reconstituted the system in vitro and performed a 
detailed kinetic analysis. We confirmed that the psudosubstrate domain is responsible 
for the autoinhibition. Surprisingly, rather than acting as an inhibitor, Par-6 activates 
aPKC by displacing the pseudosubstrate from the kinase domain. Par-6 activation of 
aPKC is consistent with our observation that the Par-6/ PKC complex, but not aPKC 




support a model in which aPKC activity is coupled to localization via Par-6. In the 
second part, I investigated how the phosphorylation activity of aPKC is coupled to 
cortical displacement of fate determinants, which often contain multiple phospho-
accepting residues. Using Lgl as a model substrate in S2 localization assays, I examined 
the role of multiple phosphorylations and found that multi-site phosphorylation is 
required for cortical release. Also, I examined how aPKC phosphorylates Lgl in an i  
vitro kinase assay and found that aPKC cooperatively phosphorylates Lgl in an ordered 
manner. These results provide new insights into howmultiple phosphorylation and 
phosphorylation rates could regulate localization behaviors of fate determinants at the 
cortex.  
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PHOSPHORYLATION BY PROTEIN KINASES AS A KEY REGULATORY 
ELEMENT IN SIGNAL TRANSDUCTION 
 The explosion of scientific interest in protein kiase-mediated signal transduction 
dates back to the 1950’s when phosphorylase kinase w  originally discovered (1,2). At 
that time, it was known that phosphorylase, a metabolic enzyme, existed in an active 
form and an inactive form (3). In a search for the molecular mechanism responsible for 
converting phosphorylase from the inactive state to the active state, Krebs, Graves, and 
Fischer discovered that phosphorylase kinase b was responsible for the catalysis of 
phosphoryl-transfer reactions (4). It was later shown that phosphorylase kinase b itself 
was subject to phosphorylation to regulate its activity (5). These two breakthroughs 
introduced the idea that phosphorylation by protein kinases is a key regulatory element. 
Since then, a myriad of protein kinases have been id tified and phosphorylation has 
been firmly established to be the most widespread form of post-translational 
modification. 
 The significance of phosphorylation as a signal is represented by the fact that 
~2% of the human genome is dedicated to encode protein kinases, corresponding to more 
than 500 protein kinases. It has been estimated that about 30 % of all cellular proteins 
undergo phosphorylation at least once (2,6,7). It is not surprising that protein kinases are 




division, differentiation, motility, trafficking, immunity, learning, memory, and more. 
Furthermore, protein kinases have been the focus of intense research efforts because 
malfunctioned and unregulated kinases have been linked to devastating diseases such as 
cancer. To develop therapeutics, scientists around the globe have been working to 
decipher the molecular mechanisms of the complex phos orylation-mediated signaling 
networks. This extensive endeavor ranges from atomic level structural studies to more 
systemic cataloging like Kinome, which is a project to identify physiological kinase-
substrate pairs in human genome and map the phosphorylation-based signaling networks 
(8). Though the scientific community has uncovered many of the mysteries, there are 
more questions to be answered to understand the entir ty of kinase signaling.  
 In this study, I intend to discuss the molecular mechanisms by which atypical 
Protein Kinase C (aPKC) is regulated via both intra- and intermolecular interactions. 
Also, I will discuss how substrate specificity and preference leading to differences in 
aPKC activity. I hope that my research results would provide insights to general 
understanding of kinase regulation.  
 
THE DAWN OF ATYPICAL PROTEIN KINASE C  
 In 1977, Nishizuka and colleagues published the first paper detailing the 
properties of the partially purified protein kinase from bovine cerebellum (9-11). In this 
paper, they showed that their enzyme phosphorylated histone and protamine in the 
presence of Mg2+, and that their kinase seemed to be converted from a proenzyme to a 
highly active enzyme by limited proteolysis. In the following years, Nishizuka and his 




the activator was, in fact, not a protein, but membrane-associate phospholipids (12). 
Interestingly, the purified phospholipids were not capable of activation unless an 
unusually high concentration of Ca2+ was present, which led to another discovery that 
diacylglycerol (DAG) was the main activator of PKC. Furthermore, they identified that 
PKC was the long-sought target of phorbol esters that function as potent tumor-
promoting analogs of DAG (13). Several PKC isoforms were identified, and each 
described in detail (11,14-20). The findings provided the information that the isoforms 
were expressed in specific tissues and cells, and that cell signaling pathways involve the 
cell membrane, temporal and spatial regulation of the target proteins via multiple 
pathways, precise controls for activity of signaling molecules, and redundancy of the 
signaling systems. These early studies established the PKC family as a model for signal 
transduction (11,21).  
 It was not until the beginning of the 1990’s that PKCζ and PKCλ/ι were first 
cloned and the subfamily of atypical protein kinase C merged (22,23). They were 
originally discovered based on amino acid sequences similar to the other PKC family 
members, but aPKCs deeply puzzled the researchers because Ca2+, DAG, and phorbol 
esters all failed to activate aPKC activity (24). It has been suggested that aPKCs are 
activated by other lipid cofactors such as phosphatitylinositols (PIs) (25), phosphatidic 
acid (26), phosphatidylinositol- (3,4,5)-triphosphate (27), phosphatidylserine (24), and 
ceraminde (27,28), but the exact activation mechanisms remain largely unknown for 
aPKCs. Nevertheless, there is a large body of evidence suggesting that aPKCs play a 
crucial role in cell growth and survival (22,23). Intense research efforts have been put 




with poor prognosis in certain cancers (29), further emphasizing the importance of 
aPKCs.  
 
aPKC AS A MEMBER OF THE PAR COMPLEX INVOLVED IN 
ESTABLISHING CELL POLARITY 
 Cell polarity is a dynamic process for living cells to create molecular distinction 
within the cell. In the event of polarization, a cell is required to establish physical 
segregation of proteins, lipids, and even organelles to the two opposing sides of the cells. 
These differentiated cellular poles play a vital role in the development of tissue structures 
and the maintenance of tissue homeostasis because the molecular polarity can define cell 
orientations, functions, and cell fates. For example, in epithelial cells, the apical domain 
faces the external environments to function as a barrier while the basolateral domain is 
attached to the underlying basal membrane through adhesion molecules to extracellular 
matrix (Fig. 1A). This apical-basolateral polarity contributes to the tissue shape and the 
direction of the transport. It has been suggested that a loss of the cell polarity in epithelial 
cells results in the tissue disorganization. When combined with the loss of cell-cell 
adhesion, unregulated polarity causes EMT and is associated with metastasis (30). 
Another type of cell polarity is observed in mammalian primary-cultured astrocytes (Fig. 
1B). When a confluent monolayer of primary rat astrocytes are wounded by scratching, 
cells initiate reorganization of the microtubule organizing center, microtubule 
cytoskeleton, and the Golgi to establish cell polarity at the leading edge. This polarity 
axis allows the cells to direct cell protrusion and migration perpendicular to the scratch 




undergoes cytoplasmic reorganization to establish anterior-posterior polarity, which cues 
the cell to divide asymmetrically and produce daughter cells with different behaviors and 
fates (33) (Fig. 1C). This process is called asymmetric cell division (ACD). Similar to C. 
elegans, in Drosophila neuroblasts, they set up molecular polarity during mitosis and 
utilize it to generate two different daughter cells with distinct fates; one remains as a 
neuroblast while the other becomes a ganglion mother cell (GMC), which further divides 
into neurons or glia cells (Fig. 1D). If ACD fails to progress properly, neuroblast would 
either be depleted or over-proliferate at the cost of neurons depending on the polarity 
defects in the fly brains. Thus, theses examples show t at the establishment and 
maintenance of cell polarity have important implications to development and tissue 
homeostasis of metazoan cells. Then, how is cell polarity established? 
 The hint for the cellular function of aPKC emerged when it was identified as a 
core component involved in cell polarity. The six par genes and PKC-3 (orthologue of 
aPKC) were first identified in C. elegans during a screen to find mutants that failed to 
establish anterior-posterior axis in the zygote. Normally, when C. elegans zygotes 
undergo the first mitosis, aPKC localizes to the anterior side of the zygote and excludes 
posterior components, such as Par-1 and Par-2, from the anterior side. However, C. 
elegans embryos lacking any of the Par complex membersconsisting of Par-3, PKC-3 
(C. elegans aPKC), and Par-6failed to induce asymmetric contraction of the myosin II 
meshwork (34-36). In Drosophila neuroblasts, the null mutant of aPKC results in not 
only mislocalized Par-6, but also uniformly cortical localization of basal determinant 
Miranda. Similarly, aPKC fails to localize at the apical cortex when Par-6 is absent from 




Figure 1. The different contexts of cell polarity and the localization of aPKC.  
 
A. Mammalian epithelial cells with apicobasal polarity, which allows them to 
function as cellular barrier. aPKC is localized to the apical membrane. 
B. Mammalian astrocytes establish polarity with respect to the direction of 
movement. aPKC is localized at the leading edge. 
C. aPKC is localized at the anterior of C.elegans zygotes which divides 
asymmetrically along the anterior-posterior polarity axis. 
D. Drosophila neuroblasts divide asymmetrically based on apical-basal polarity axis. 
aPKC is localized at the apical cortex. The figure is modified from [31].  
 
  
function as the mutation of phosphorylation site impairs the Par-complex function 
(38,39). However, Bazooka shows slightly different localization from aPKC in 
Drosophila. In apkc null neuroblasts, Bazooka is still able to localize at the apical cortex, 
which suggests that it is upstream of aPKC (37). In mammalian epithelial cells, the Par 
complex is coupled to junction formations. Upon cell- ll contact, the Par complex is 
recruited to the spot-like adherens junctions (AJs) (40 , which mature and differentiate 
into belt-like AJs and tight junctions (TJs). These junctional structures are located at the 




overexpression of a dominant-negative aPKC or Par-3 prevent the transition of AJs from 
spot-like to belt-like forms (31,40). The overwhelming evidence suggests that the Par-
aPKC system is evolutionarily conserved proteins in function and plays an essential role 
in many different types of metazoan cell polarity. Also, these data suggest that 
localization of the Par complex is codependent and that the Par complex establishes 
polarity by somehow excluding proteins from an aPKC-containing domain. 
 A more mechanistic understanding of aPKC comes from the findings that 
expression of aPKC kinase-inactive mutant disrupts the assembly of TJs in mammalian 
and Drosophila epithelial cells (40,41). Also, it has been shown that aPKC directly 
interacts with Par-6 to form a stable dimer, and immunoprecipitation-coupled kinase 
assays show that the interaction with Par-6 represses aPKC activity (42). Furthermore, 
some of the differentiation factors that are excluded from aPKC-containing side of the 
membrane are aPKC substrates. Consistent with the kinase-dead mutant phenotypes, non-
phosphorylatable mutant of Mira and Lgl in neuroblasts fail to be excluded from the 
apical cortex of the cell and remain uniformly cortical (43,44). Similarly, a non-
phosphorylatable Numb mutant colocalizes with aPKC in SOP cells while wild type 
protein does not colocalize with aPKC (45). Taken toge her, it is clear that 
phosphorylation of several differentiation factors by aPKC is indispensible for the 
establishment of polarity, and aPKC activity is regulated by Par-6. However, little is 






STRUCTURAL DIVERGENCE OF ATYPICAL SUBCLASS RESPONSIBLE 
FOR THE DIFFERENCE IN ACTIVATION MECHANISMS 
 The activation mechanism of aPKC is not well understood, partially due to the 
fact that its domain structure differs from the other PKC family members. All PKC 
isoforms contain regulatory domains located in the N-terminus and highly conserved 
catalytic domains in the C-terminus. These isoforms are divided into three classes based 
on the regulatory domains: classical or conventional PKC (cPKC), novel PKC (nPKC), 
and atypical PKC (aPKC) (Fig. 2). Here, I discuss each domain of aPKC in detail to 
clarify the basis of the activation mechanism differences compared to the members of 
PKC family.  
 
PB1 domain 
 Modular domains often facilitate specific protein-protein interactions and play 
important roles in cellular functions. PB1 domains are dimerization domains present in 
scaffold proteins, conserved among amoebas, fungi, plants, and animals (46). They are 
about 80 amino acid long and form a ubiquitin-like compact globular fold, consisting of 
six-stranded β-sheets and two α-helices. Previous structural studies show that the PB1-
PB1 interaction involves specific electrostatic contacts between a cluster of acidic amino 
acids of type I PB1 and the few basic residues including, invariant Lys of type II PB1 
(46-48). A PB1 domain resides in the N-terminus of the aPKC regulatory domain, and is 
classified as type I/II because both the acidic cluster and the conserved Lys residue are 




Figure 2. The domain structures of PKCs.  
The regulatory domain of the cPKC class, which includes PKCα, βI, βII, and γ, consists 
of a pseudosubstrate motif in the N-terminus (a short stretch of amino acids that 
resembles the substrate binding motif except the phos ate-accepting Ser/Thr residue is 
replaced to Ala), twin C1 domains (tandem 50 residue long domains, C1A and C1B, 
containing 6 Cys and 2 His residues that coordinate 2 Zn2+ ions. They are responsible for 
DAG/phorbol esters sensitivity), and a C2 domain (Ca2+-dependent, membrane-
targeting). The nPKC class includes PKCδ, ε, θ, and η, and contains a novel C2 domain 
in the N-terminus (C2 domain in nPKC differ from cPKC because it lacks the Ca2+-
coordinating acidic residues. For this reason, nPKC isoforms are unresponsive to Ca2+), a 
pseudosubstrate motif, and a pair of C1 domains. Finally, the regulatory domain of the 
aPKC class contains a PB1 domain (a dimerization domain to interact with other PB1-
containing proteins), a pseudosubstrate motif, and a C1 domain (unlike the other PKCs, 
aPKCs only have one copy of C1 domain. Also, it has only one Zn2+ ion and lacks crucial 
basic residues for the interaction with DAG/phorbol esters). The figure is modified from 
[41].  
 
residues in PB1 of Par-6, as yeast two-hybrid data and localization study in MDCK cells  
show that the mutations of either a critical acidic reside in aPKC PB1 or the conserved 
Lys in Par-6 PB1 disrupted the interaction (49). Furthermore, the X-ray crystallography 
data show that the two PB1 domains interact with each other via the charged regions in a 
front-to-back manner (50) (Fig. 3). The interaction with Par-6 is important for the 
localization of aPKC in polarized cells as loss of Par-6 is shown to correlated with 
mislocalized aPKC (37); however, it is not known how this interaction leads to 







Figure 3. The crystal structure of PB1-PB1 dimer between PKCι/λ (blue) and Par-6α 
(yellow).  
 
The complementary electrostatic charges allow the two domains to interact. The acidic 
residues of aPKC PB1 (red) and the basic residues of Par-6 (blue) are shown at the 
binding interface. PDB 1WMH 
 
Pseudosubstrate motif 
 The presence of a cis-acting autoinhibitory motif is a common regulatory feature 
of protein kinases. Generally, a pseudosubstrate moif is a short stretch of amino acid that 
acts as a competitive inhibitor of the kinase activity since it resembles the substrate 
recognition sequence except that the phospho-accepting Ser/Thr residue is substituted to 
Ala and blocks the substrate binding (51). It was originally shown that the addition of 
synthesized PKC peptide that resembled the substrate phosphorylation site in trans 
reduced the catalytic activity of PKC in a dose-dependent manner. Kinetic analyses 
showed that the peptide inhibited PKC in a competitiv  manner, suggesting that it acted 




domain (52). Consistent with these data, while the PKC pseudosubstrate is protected from 
proteolysis when it is in an inactive state, it is highly sensitive to proteolysis upon 
activation (53). Extensive biochemical studies have indicated that binding to the 
activating lipid cofactors at the membrane supplies th  energy necessary to release the 
PKC pseudosubstrate motif (54). However, since the lipid cofactors that activate PKCs 
do not activate aPKC, it is unclear whether aPKC pseudosubstrate motif autoinhibits the 
catalytic activity and is released in the same mechanism observed in PKCs.  
 
C1 domain 
 In cPKC and nPKC, a pair of C1 domains, C1A and C1B, serves as membrane-
targeting modules that bind DAG and phorbol esters for activation (55-59). They are 
characterized by the presence of six Cys and two His motif that coordinate two Zn2+ ions 
(each Zn2+ ion is coordinated by three Cys and one His). In co trast, there is only one C1 
domain in aPKC. Although there are six Cys and two His residues similar to the other 
PKCs, aPKC C1 domain only contains one Zn2+. Also, it is insensitive to both DAG and 
phorbol esters. The unresponsiveness to the lipid act vators is attributed to a cluster of 
basic residues present in the domain (KRFN RAFC). When four Arg residues are 
substituted to corresponding (uncharged) residues from PKCδ C1B domain, aPKCζ 
recovers the sensitivity to phorbol esters. Similarly, substitution of the residues from 
PKCδ C1B at the same position to Arg abolishes the sensitivity to phorbol esters (60).   
 Even though aPKC C1 domain does not interact with the known lipid activator, it 
may still function as membrane translocation module ( npublished data from Prehoda 




cortical localization (unpublished data). Additionally, the bacterially purified aPKC C1 
domain interacts with certain phospholipids n vitro. Many questions remain as to the 
function of aPKC C1 domain, and it is of particular interest how aPKC localization via 
C1 domain is coupled to activation of its catalytic activity.  
 
Catalytic domain  
 In general, catalytic domains of eukaryotic Ser/Th protein kinases including 
aPKC are very well conserved and have similar tertiary structures (Fig. 4A). They are 
composed of an amino-terminal small subdomain (N-lobe) and a carboxyl-terminal large 
subdomain (C-lobe). The bilobal fold of protein kinases enables dynamic movement to 
assume different conformations and allows kinases to regulate their catalytic activity in 
response to cellular signals. There are several key features within the catalytic domain 
that regulate the coordinated movements for optimal phosphotransfer. 
 
1. ATP binding site  
 One of the most conserved motifs within catalytic domains among the different 
kinases is a glycine-rich loop (consensus sequence of the loop is GXGXXG), which 
provides necessary flexibility for anchoring ATP. The loop is also important for 
excluding water to avoid unwanted hydrolysis of an ATP molecule. However, the third 
glycine of aPKC is replaced with alanine (61). This unique loop structure is reflected by 
the interaction between ATP and the “invariant lysine” the most conserved and best 





Figure 4. The structural features of aPKC catalytic domain.  
 
A. The overall structure of human PKCι (PDB: 1ZRZ) showing the bilobal 
architecture with the activation loop and the turn motif.  
B. ATP binding pocket and the substrate binding site. In a deep cleft between the 
two lobes is a binding site for one ATP molecule, and substrates bind across the 
front end of the ATP-binding pocket close to the γ-phosphate. In this figure, 
AMPPCP occupies the ATP binding site and Par-3 peptid  substrate is bound at 
the substrate binding site (PDB: 4DC2). 
C. Both activation loop with the phosphorylated T403 (cyan, PDB: 1ZRZ) and non-
phosphorylated T403 (magenta, PDB: 4DC2) assume the active conformation. 
Phosphorylated T403 interacts with R368, K392, T401, and Y420 to order the 
loop. Non-phosphorylated T403 only interacts with Y420.  








β-phosphates to anchor and orient the ATP molecule. Also, it forms a salt bridge with the  
carboxyl group of one of the glycine residues in the loop and stabilizes the three- 
dimensional structure of the catalytic domain (6,7). Typically, when this Lys residue is 
mutated to other amino acids including chemically similar Arg results in inactivation. In 
contrast, substitution of Lys to Arg in aPKC exhibits normal catalytic activity (61). These 
data indicates that the ATP-binding pocket of aPKC may differ from other kinases, 
including other PKC family members. 
 
2. The activation loop   
 Many kinases require one or more phosphorylation event on the activation 
segment, which is defined as a stretch of 25-30 residu  between two conserved 
tripeptide motifs (DFG and APE) within the C-lobe. The activation segment consists of 
the Mg2+ binding loop, the activation loop, and P+1 loop. The segment could adopt a 
variety of conformations when it is not phosphorylated and kinases are in inactive states. 
Once phosphorylated and active, however, the loop undergoes a dramatic conformational 
change to correctly align the residues involved in catalysis and provides a platform for 
the substrates (Fig. 4B) (7,62,63). The crystal structures of cyclic AMP-dependent 
protein kinase (PKA) (64), a cell cycle-dependent protein kinase (Cdk2) (65), and 
mitogen-activated protein kinase (66) have showed that the phosphorylated residue in the 
activation segment interacts with a pocket of positively charged patches on the surface of 
the kinase domain. These data reveal a common mechanism by which phosphorylation of 




  In the case of aPKC, the requirement for the negative charge on the activation 
loop has been controversial (Fig. 4C). The crystal tructure of human aPKCι has shown 
that the loop was phosphorylated and the catalytic domain was in an active form (67,68). 
Other studies have shown that aPKC and other PKC family members require a negative 
charge at the activation loop and that 3-phosphotidylinositide-dependent kinase -1 (PDK-
1) is responsible for the phosphorylation (69-72). Either mutation of the phospho-
accepting residue or deletion of PDK-1 results in reduced aPKC catalytic activity (70). 
However, another crystal structure of human PKCι with a physiologically relevant 
peptide substrate from Par-3 shows that the kinase domain can assume the same active 
conformation in the absence of the activating phosprylation at the activation segment 
(73). The discrepancy may originate from that the kinase domain used for the crystal 
structure was a mutant whose invariant lysine was mutated to arginine, which is reported 
to be enzymatically active as mentioned above. It is of interest whether phosphorylation 
of the activation segment is required for aPKC or if the invariant lysine mutant does not 
require the negative charge on the loop to coordinate the substrate platform. It is also 
interesting to examine if the excess amount of peptid  substrate present in the 
crystallization condition could order the substrate binding platform in the absence of the 
phosphate group on the activation segment. 
 
3. Turn motif and hydrophobic motif 
 For PKC family members, the phosphorylation of the activation segment triggers 
phosphorylation of two additional sites (51,74). This series of phosphorylation events is 




phosphorylation occurs at the turn motif, which is a motif located in a proline-rich 
domain of the kinase domain and positioned at the apex of the N-lobe in the three 
dimensional structure (Fig. 4D). The inactive kinase expressed in cultured mammalian 
cells lacks the phosphate group at the turn motif (75). The selective dephosphorylation of 
the turn motif from classic PKCβII results in inactivation of the kinase activity (76). 
However, the turn motif is not phosphorylated unless the activation loop is 
phosphorylated by PDK-1. Biochemical evidence shows that the negative charge at the 
turn motif locks the kinase in the catalytically competent conformation (51). It is unclear 
whether the turn motif plays a role in aPKCs. Considering the similarity of the primary 
sequence between the other PKC family members and aPKCs, it is likely that the turn 
motif phosphorylation plays an important role in the maturation of aPKC catalytic 
domain. Also, all the crystal structures of PKCι which are in the active conformation 
show the presence of a phosphate group at this position (67,68,73). Further investigation 
is required to clarify if aPKC follows the trend of the other PKCs.  
 The second phosphorylation site is at the hydrophobic motif, which is C-terminal 
of the turn motif. It has been shown that this siteis autophosphorylated in PKC isozymes 
with the exception to PKCδ (77), which an upstream kinase is shown to phosphorylate at 
this position. It has been suggested that the negative charge at the hydrophobic motif may 
not be critical to the catalytic activity of the enzymes because mutation of the phospho-
accepting serine to alanine still generates activatable PKCα and PKCβII (51). In the case 
of aPKC, the phospho-accepting residue is substituted to a phospho-mimetic glutamic 
acid (68). Balendran and colleagues showed that the hydrophobic motif of aPKC serves 




ability of aPKC to interact with PDK-1 (78). However, the mutation of the acidic residue 
did not affect the interaction. Thus, more investigation is needed to decipher the exact 
role of the phospho-mimetic residue in the aPKC hydrophobic motif.  
4. PDZ ligand 
 The C-terminal tails are the most variable part of the otherwise well-conserved 
PKC family members. Recent studies indicate that this region is a critical determinant for 
isoform -pecific targeting and cellular functions (55). In the case of PKCε and PKCδ, the 
tail regions play important roles in determining the isoform-specific localization and 
biological functions (79). Also, they are critical for the catalytic competence of PKCε, for 
deletion of the tail residues reduces the phosphorylation activity in a length-dependent 
manner (80). Similarly, truncation of the last 10 residues from PKCα leads to 
acatalytically inactive kinase, due to the lack of activation loop phosphorylation (81). 
Interestingly, modeling studies for both PKCε and PKCα showed that the tail regions 
intramolecularly interacted with the N-lobe. The interaction influenced the structure of 
the ATP binding site and ultimately their enzymatic activity (55). These data suggest that 
the very distal portion of the PKC kinase domain signif cantly impact the catalytic 
competence.  
 Additionally, PKCα and aPKC contain a PDZ domain consensus binding motif
(PDZ ligand) at the C-terminal tail and have been repo ted to interact with PDZ domain-
containing proteins. For example, PDZ ligand of PKCα interacts with PICK1, which 
serves as a scaffold to localize the kinase by associating with itself and other PDZ 
domain-containing proteins at the membrane (82). Also, PDZ domain of Discs Large 




(83). In C. elegans embryos, a PDZ-PDZ ligand-mediated interaction betwe n Par-6 and 
aPKC has been shown to be dispensable for the localization of Par-6 because mutations 
that abolish the interaction did not affect Par-6 functionality (84). It is unclear whether 
PDZ ligand of aPKC plays regulatory roles with Par-6. However, the kinetic analyses of 
the complex between Par-6 and an aPKC PDZ ligand-deleted mutant show reduced 
activity (unpublished data). Also, PDZ ligand deletion mutant localizes in the cytoplasm 
of neuroblasts (unpublished data). Our data suggest that aPKC PDZ ligand is involved in 
both regulating the catalytic activity and localizat on. It is of interest to clarify this 
discrepancy as well as to examine how PDZ ligand-meiat d regulation of aPKC would 
tie into the rest of the complex network of aPKC activation mechanism.  
  
BRIDGE TO CHAPTER II 
 As described above, there are many components that could regulate the catalytic 
activity of aPKC. However, it is not well understood how all these elements participate in 
controlling aPKC in a concerted manner. In the following chapter, I discuss how the 
intramolecular interaction within aPKC regulates its catalytic activity. Also, I challenge 
the standing model that Par-6 represses aPKC activity. Previous study indicated that 
aPKC on its own is constitutively active, though it contains autoinhibitory 
pseudosubstrate domain. The inhibitory mechanism of Par-6 is also unclear. To 
understand the complex regulatory network of aPKC, I realized that aPKC must be 
purified, not immunoprecipitaed. Also, I needed a method that directly measured the 
phosphorylation rates using physiologically relevant substrates instead of the traditional 




constituents, were immunoprecipitated from cellular lysate and mixed with a generic 
substrate to test the kinase activity. This method inherently presents three issues: 1) other 
proteins that directly and indirectly interact with the target kinase will be present in the 
assay, and 2) the concentration of the kinase will be unknown, and 3) the readout of the 
kinase activity is qualitative not quantitative. In the following chapter, I describe the 
intricate regulatory mechanism of aPKC using both a reconstituted system as well as 
cellular context.  
 Chapter II and III includes previously published and unpublished co-authored 




















PARTITIONING-DEFECTIVE PROTEIN (PAR-6) ACTIVATES ATYPICAL 
PROTEIN KINASE C BY PSEUDOSUBSTRATE DISPLACEMENT 
 
This chapter contains previously published co-authored material taken with permission 
from: 
 
Graybill, C., Wee, B., Atwood, S. X., and Prehoda, K. E. (2012) Partitioning-defective 
protein (Par-6) activates atypical Protein Kinase C by pseudosubstrate displacement. 
Journal of Biological Chemistry. 287(25):21003-11. 
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The Par complex functions to create distinct, polarized cortical domains by 
coupling phosphorylation to cortical release (43,45,85). Through mechanisms that are 
still being elucidated, the Par complex becomes polarized to one cortical domain and 
keeps other, cell-type specific factors, localized to an opposite cortical domain (86-88). 
The activity of aPKC is a key output of the Par complex as the association of substrates 




Drosophila neuroblasts the protein Miranda localizes to a cortical domain opposite the 
Par complex and its polarization requires aPKC activity (43). Miranda associates with the 
cortex via its cortical localization domain, but once this domain is phosphorylated by 
aPKC it is released into the cytoplasm leading to their mutually exclusive localization. 
Cortical association of the protein Numb is also modulated by aPKC phosphorylation, 
both in Drosophila and polarized mammalian cells (45), suggesting that coupling of 
aPKC-mediated phosphorylation to cortical displacement may be a general mechanism 
for Par-mediated polarity. 
That activity of aPKC must be maintained within a certain range. In humans, 
inappropriate aPKC activity is associated with epithel al tumors (89,90). Ectopic aPKC 
activity in neuroblasts leads to massive overproliferation and concomitant loss of 
differentiated cells (91). In current models, aPKC activity is controlled by a complex set 
of protein-protein “scaffolding” interactions (87,92). In particular, Par-6 is thought to 
repress aPKC (42,85,93), suggesting that aPKC may have a high level of constitutive 
activity. Par-6 repression of aPKC is thought to be important in Drosophila sensory organ 
precursor (SOP) cells where aPKC activity is highly dynamic during mitosis (85). Early 
during SOP division, aPKC is held in an inactive complex along with Par-6 and the tumor 
suppressor Lethal giant larvae (Lgl). Activation is proposed to occur by phosphorylation 
of the Par-6 PB1 domain by the mitotic kinase Aurora A. As the PB1 domain is the 
interaction site with aPKC (48,50,94), Par-6 dissociates from aPKC allowing Lgl to be 
phosphorylated and released from the complex. Finally, the Par complex member Baz 




activity is maintained within appropriate levels byd namic scaffolding interactions has 
been unclear. 
 Although protein-protein interactions are thought to regulate aPKC, the precise 
mechanisms that control catalytic activity have been unclear. All PKC isoforms contain 
NH2-terminal domains that are potentially important for controlling the activity of the 
COOH-terminal kinase domain (74). These domains include the aPKC-specific PB1 that 
binds Par-6 (50), and the C1 domain that binds lipid cofactors such as diacylglycerol in 
other PKC family members (95,96), but whose function n aPKCs is unknown (60). 
PKCs also contain a short pseudosubstrate motif tha resembles a true substrate but lacks 
a phosphorylatable residue, making it capable of acting as a competitive inhibitor. In 
other PKC isoforms the pseudosubstrate autoinhibits ca alytic activity, but its role in 
regulating aPKC is unclear. In this work, we explore the interplay between internal aPKC 
regulatory elements and the protein-protein interactions that are thought to control aPKC 
activity during cell polarization.  
 
MATERIALS AND METHODS 
 
Purification of aPKCs and aPKC/Par-6 complex 
 HEK293 F cells were transfected with pCMV His6-aPKC constructs for expression 
of individual aPKC variants or co-transfected with pCMV His6-Par-6 and pCMV aPKC 
(no his tag) for expression of the aPKC/Par-6 complex using the 293fectin transfection 
reagent (Life Technology). The cells were incubated at 37 °C for 72 hours followed by 




added to the supernatant to a final concentration of 45% (w/v) and incubated at 4 °C for 
30 min. The resulting precipitate was collected by centrifugation at 15,000 rpm for 30 
min. at 4 °C and resuspended with Ni2+ lysis buffer (50 mM NaH3PO4, 300 mM NaCl, 10 
mM Imidazole, adjusted to pH 8.0 with NaOH). The resuspended precipitate were 
incubated with Ni2+ NTA resins for 45 min at 4 °C. The resins were washed with the lysis 
buffer. The proteins were eluted using Ni2+ elution buffer (50 mM NaH3PO4, 300 mM 
NaCl, 250 mM Imidazole, adjusted to pH8.0 with NaOH). The eluted proteins were 
dialyzed at 4 °C for 4 hours. For the complex with Par-6, the proteins were further 
purified with a size exclusion column (S200 10/30; GE Health). The concentration of 
aPKC was determined by comparing its reactivity with an anti-aPKC antibody (Santa 
Cruz Biotech) with that of a standard of known concentration (bacterially expressed 
aPKC kinase domain purified and quantified using a Br dford dye binding assay) on a 
western blot.  
 
Expression and purification of Lgl and Baz 
 Full-length and residues 647-673 of Drosophila Lgl isoform A and Baz residues 
905-1221 of isoform A (constituting the aPKC binding region) were cloned into pMAL-
C2 vector (New England BioLabs Inc.), in which a TEV protease recognition site was 
added following the MBP coding sequence. The residues S656 and S660 in Lgl 647-673 
were mutated to alanines. The constructs were transformed into BL21 E. coli cells. The 
expressions were induced by 0.4 mM IPTG at 18 °C overnight. The bacterial lysates were 
incubated with amylose resins (New England BioLabs Inc.). The resins were washed with 




The MBP-fusion proteins were eluted with MBP elution buffer (20 mM TrisHCl pH 
7.5, 200 mM NaCl, 1 mM EDTA, 1 mM DTT, 5 mM Maltose) and dialyzed at 4 °C  
overnight in 20mM TrisHCl pH7.5, 50mM NaCl. The affinity purified proteins were 
further purified by ion exchange.  
 
Affinity chromatography “pulldown” binding assays 
 GST pulldowns were as previously described (97). Briefly, Drosophila aPKC 120-
141 was cloned into pGEX-4T1 (GE Healthcare Life Scien es) which was transformed 
into E. coli strain BL21. Protein expression was induced by 0.4 mM IPTG at 18 °C 
overnight. The bacterial lysate was incubated with GST agarose (Sigma-Aldrich) at 4 °C 
for 15 min. The GST resins were washed with 1x GST pulldown buffer (20 mM HEPES, 
100 mM NaCl, 5 mM MgCl2, 1 mM DTT, 0.5 % Triton X-100) for 3 times. For the 
experiment in Figure 1E, 30 µg of His-aPKC A134D was added along with 10, 20, 40, 
80, or 100 µM MBP-Lgl 647-673 S656A S660A peptide and incubated at room 
temperature for 20 min in a reaction volume of 100 µL. The supernatant was removed 
and added to amylose resin (New England Biolabs). Both resins were washed with 1x 
GST pulldown buffer 3 times. 30 µL of 6x SDS loading buffer was added to each sample 
followed by separation on SDS-PAGE and transfer to nitr cellulose. The membrane was 
probed for aPKC with rabbit anti-aPKCzeta (1:2000) (Santa Cruz). The membrane was 
further incubated with goat anti-rabbit peroxidase-conjugated secondary antibody and 






In vitro kinase activity assay 
 aPKC kinase activity was measured as previously described (98). Briefly, the 
purified aPKC variants and aPKC/Par-6 complex were diluted to concentrations at which 
the incorporation of radiolabeled phosphate from [γ-32P]ATP into MBP-Lgl peptide was 
linear with respect to time and the enzyme concentrations. The diluted enzymes were 
preincubated in the assay buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 10 mM 
MgCl2) with a wide range of MBP-Lgl peptide concentrations at 30 °C for 5 min. The 
reactions were initiated by adding 1mM ATP spiked with [γ-32P]ATP (~1.0 x 105/nmol 
ATP). The reactions were incubated at 30 °C for 10 min. The reaction mixtures were 
blotted on Grade P81 phosphopaper (Whatman). The reactions were quenched by 
immediately submerging the blotted P81 paper in 75 mM H3PO4. 5mL of scintillation 
fluid were added to measure the radioactive decays by liquid scintillation counter. For 
phosphorylation of Lgl full-length, the reactions were quenched by mixing with 6x SDS 
loading buffer. The quenched samples were analyzed by 12.5 % SDS-PAGE and 
phosphorimager. The intensities were analyzed by ImageQuant.  
 
Arg-C proteinase sensitivity assay 
 Arg-C proteolysis was described previously (99). 30 µg of aPKC variants or 
aPKC/Par-6 complex were incubated with 1 µg of endoproteinase Arg-C proteinase 
(Sigma-Aldrich) at 37 °C for 120 min. Aliquots were removed at 0 and 120 min into 
equal volume of 6x SDS loading buffer. As negative control, aPKC variants were 
incubated at the same conditions without Arg-C proteinase. The samples were separated 




performed to probe for aPKC proteolysis as described above.  
 
S2 Lgl cortical localization assay 
 Immunofluorescence was as previously described (100). Briefly, For S2 cell 
expression, aPKC was expressed using transient transfection with a modified pMT vector 
containing the Drosophila tubulin promoter in place of the metallothionen promoter. 
Myc:Par-6 and HA:Lgl coding sequences were cloned ito the regular pMT vector using 
5’-BglII and 3’-XhoI sites. Drosophila Schneider (S2) cells were maintained in 
Schneider's Medium with 10% FBS at room temperature. ~2x106 cells were seeded per 
well in a 6-well plate and transfected with 0.5 µg of each construct using Effectene 
transfection reagent according to the manufacturer's protocol. After cells were incubated 
overnight and induced with 0.5 mM CuSO4 for 24h, 200µL of cells were seeded on 12 
mm diameter glass coverslips in a 24-well plate and llowed to adhere for 1h. Cells were 
fixed for 20 minutes with 4% formaldehyde in PBS followed by 3 rinses of wash buffer 
(0.1% saponin in PBS) and two rinses of block buffer (0.1% saponin and 1% BSA in 
PBS). Coverslips were incubated overnight at 4oC with the following primary antibodies: 
rabbit anti-aPKC (1:1000; Santa Cruz Biotechnology), mouse anti-HA (1:1000; 
Covance), rat anti-Par6 (1:1000; in house). Coverslips were then rinsed 3x with blocking 
buffer, incubated at room temperature for 2h with species-specific secondary antibodies 
(1:200; Jackson Immunoresearch), rinsed 3x in washing buffer, and mounted in 
Vectashield Hardset Mounting Medium (Vector Laboraties). Images were acquired on 
a confocal microscope (Radiance; Biorad laboratories) using an oil-immersion 60x 




Phosphorylation-coupled MBP pulldown assay 
 100 µg of the purified MBP-Lgl full-length and MBP-Lgl 647-673 S656A S660A 
peptide were incubated with amylose resins (New England BioLabs Inc.) for 20 min at 
room temperature. The resins were washed with 1x MBP pulldown buffer (20 mM 
HEPES, 100 mM NaCl, 5 mM MgCl2, 1 mM DTT, 0.5 % Tween 20) for 3 times and 
once with kinase assay buffer (50 mM TrisHCl pH 7.5, 100 mM NaCl, 10 mM MgCl2). 
30 µg of aPKC wt/Par-6 complex was added to the washed resins with or without 0.5 
mM ATP to allow phosphorylation. The reaction mixtures were incubated at 30 °C for 1 
hour. The reaction volume was 500 µL. The resins were ashed with 1x MBP pulldown 
buffer for 3 times. 6x SDS loading buffer was added to each sample. The samples were 
separated by 12.5% SDS-PAGE and binding was analyzed by western blots probing for 




aPKC is autoinhibited by its pseudosubstrate 
 We first identified internal elements within aPKC tha  regulate its kinase activity 
(aPKC domain structure is shown in Fig. 5A). In current models for aPKC regulation, 
Par-6 represses kinase activity (42,85,87,93), suggesting that aPKC might be 
constitutively active. This model originates from exp riments using immunoprecipitated 
aPKC and/or bacterially expressed Par-6 (42,93), in some cases with a non-specific 
substrate. To rigorously test aPKC regulation, we us d high level expression in HEK293 




variable degrees of purity of the final products, depending on the aPKC variant (a 
schematic of aPKC variants used in this study are shown in Fig. 1B; Supplemental Fig. 
S1A). Additionally, there was little difference in the d gree of activation loop 
phosphorylation among the variants, with the exception that the K293W ATP-binding 
pocket mutant (101) showed severely reduced modification (Supplemental Fig. S1B). We 
measured the activity of these preparations in in vitro kinase assays using a peptide from 
Lethal giant larvae (Lgl), a known substrate (44,102 3). Lgl contains three 
phosphorylatable serines but we mutated two of them to alanine so that only a single site 
is available for phosphorylation to simplify the analysis (Fig. 5C). We measured initial 
rates of catalysis by following the transfer of a radiolabeled-phosphorous from ATP to 
the Lgl peptide over a range of substrate concentrations (i.e. a Michealis-Menten 
analysis). 
 We first compared the activities of full length aPKC to that of its isolated kinase 
domain. We observed significant levels of activity for the kinase domain but full-length 
aPKC’s activity was approximately equal to background activity, as assessed by 
measuring the activity of the ATP binding pocket mutant K293W (Fig. 5D), which 
results in an inactive kinase (101). The low activity of full length aPKC precluded 
measurement of accurate KM and kcat values for this protein but analysis of initial rates of 
the kinase domain yielded values of 4 µM and 1.8 s-1, respectively. These values are 
similar to those from other catalytic domains from the AGC family of kinases (104,105). 
The dramatic difference between the activity of full-length aPKC and its isolated kinase 





 To identify domain(s) that inhibit aPKC’s activity, we measured the rates of 
substrate phosphorylation by variants that lacked indiv dual domains within the NH2-
terminal regulatory region. Like other PKC family me bers, aPKC contains a 
pseudosubstrate motif that can act as an internal competitive inhibitor. A peptide 
containing the pseudosubstrate sequence competes with binding of true substrates (Fig. 
5E) suggesting that the pseudosubstrate can interact with he kinase domain active site. 
This conclusion is further supported by phosphorylation of the pseudosubstrate when the 
alanine residue that would sit in the active site is mutated to a serine residue (Fig. 5F). 
Consistent with these observations, deletion of pseudosubstrate domain dramatically 
increased aPKC activity indicating that it is required for aPKC autoinhibition (Fig. 5G). 
To further characterize the pseudosubstrate’s role in autoinhibition, we made versions of 
aPKC with point mutations in residues thought to be critical for its interaction with the 
kinase domain. Mutation of the key alanine residue to a phosphomimetic aspartic acid 
increases kinase activity presumably by causing “substrate release”. Additional mutation 
of basic residues near the phosphorylated residue that are important for kinase domain 
interaction also increase aPKC activity (Fig. 5G). Thus, the pseudosubstrate is a critical 
element of aPKC autoinhibition. 
 We also tested the role of other aPKC domains in regulating catalytic activity. In 
contrast to the pseudosubstrate, the PB1 domain, which mediates interaction with Par-6, 
does not directly regulate aPKC activity as its deletion had no detectable effect on 
catalytic activity (Fig. 6A). The aPKC sequence also contains a C1 domain directly 
COOH-terminal to the pseudosubstrate. In other PKC isoforms, the C1 binds 




increased aPKC activity to a level similar to pseudosubstrate mutants (Fig. 6A) 
demonstrating it plays a critical role in synergizing with the pseudosubstrate to maintain 
the autoinhibited state. 
 
Figure 5 (next page). aPKC is autoinhibited by its pseudosubstrate motif.  
 
A. aPKC domain structure. An alignment of the the pseudos bstrate motifs from flies 
(Dm), humans (Hs), and fish (Dr) is shown with the alanine that is in the position 
of the phosphorylatable residue in a typical substrate starred.  
B. Lgl domain structure. LCR, low complexity region. The three residues 
phosphorylated by aPKC are shown, as is the peptide that was used for the 
majority of the kinase activity assays showing the p osphorylation sites that were 
removed by mutation to alanine.  
C. aPKC constructs used in this study.  
D. Comparison of full-length aPKC catalytic activity to that of the isolated kinase 
domain. The initial rate of phosphorylation (µmol/minute) of a Maltose binding 
protein fusion of the Lgl peptide (MBP-Lgl peptide; see panel B) is shown for 
three aPKC variants: the isolated kinase domain, full-length, and K293W which 
disrupts the ATP binding site of the kinase domain. 
E. The pseudosubstrate interacts with aPKC and the Lgl peptide competes with their 
interaction. Addition of MBP-Lgl peptide reduces the amount of aPKC retained 
on glutathione agarose beads adsorbed with a GST fusion of the aPKC 
pseudosubstrate (top western). The supernatant was adsorbed onto amylose resin 
(bottom western) to confirm that the MBP-Lgl fusion f rmed a complex with 
aPKC. The A134D aPKC pseudosubstrate variant (see pan l B) was used for the 
pull-down so that the internal pseudosubstrate did not compete with the pull-
down.  
F.  The pseudosubstrate containing an alanine to serine mutation is readily 
phosphorylated by aPKC. Comparison of the initial phosphorylation rate of a GST 
fusion of the pseudosubstrate containing mutation A134S (starred residue in panel 
A) to MBP-Lgl peptide. The “AADAA” aPKC pseudosubstrate variant (see panel 
B) was used for the kinetic assay. 
G. Perturbation of the pseudosubstrate activates aPKC. ∆PS, aPKC that lacks the 
pseudosubstrate; A134D, aPKC containing an aspartic acid in place of the starred 
alanine in panel A; AADAA, aPKC that contains A134D along with mutations in 
adjacent basic residues that interact with the kinase domain. The activity of full-












 To further dissect the role of the pseudosubstrate in r gulating aPKC, we took 
advantage of a protease sensitivity assay in which pseudosubstrate cleavage by Arg-C is 
inhibited by its interaction with the kinase domain (99). The aPKC sequence contains two 
arginine dipeptides that are located in its pseudosbstrate and could potentially be 
cleaved by Arg-C (Fig. 5A). However, we observed no cleavage of full length wild-type 
aPKC with Arg-C over the course of 120 minutes (Fig. 6B), consistent with its low 
catalytic activity. In contrast, the version of aPKC with an aspartic acid mutation in 
pseudosubstrate domain (A134D), which we found to be highly active in the kinase 
assay, is Arg-C sensitive. Mutation of the pseudosubstrate basic residues to alanine in the 
context of the activating A134D mutation (AADAA) abolished protease sensitivity, 
confirming that the pseudosubstrate is the cleavage site. Interestingly, we found that 
removal of the C1 domain increases Arg-C sensitivity of the pseudosubstrate indicating 
that the C1 functions to regulate aPKC activity by assisting pseudosubstrate interaction 
with the kinase domain. Thus, deletion of the C1 likely causes a dramatic change in the 
conformation of aPKC. Taken together, these results indicate that pseudosubstrate 
protease sensitivity is correlated with catalytic activity, further supporting a model in 
which aPKC is autoinhibited by the synergistic activity of C1 and pseudosubstrate. 
 While our data indicates that aPKC is autoinhibited n vitro, we sought to 
determine if it is also autoinhibited in a cellular context. The aPKC substrate Lgl 
localizes to the cortex of cultured Drosophila S2 cells but phosphorylation by aPKC 
causes its displacement into the cytoplasm. When aPKC is expressed with Lgl, a 
significant fraction remains co-localized at the cortex, consistent with aPKC 




pseudosubstrate is mutated (leading to high activity in vitro), Lgl is efficiently displaced 
from the cortex. Thus, both in vitro and in a cellular context, aPKC is autoinhibited. 
 
Figure 6. The C1 and pseudosubstrate synergistically repress aPKC activity.  
 
A. Deletion of the PB1 domain has no effect on aPKC catalytic activity whereas loss 
of the C1 activates aPKC. The activity of the isolated kinase domain and full-
length aPKC, both intact and lacking the pseudosubstrate, are shown for 
comparison.  
B. Mutations that activate aPKC are sensitive to the Arg-C protease. Arg-C protease 
cleaves at the arginine dipeptides that are located solely in the aPKC 
pseudosubstrate. Wild-type aPKC is insensitive to Arg-C, presumably because the 
pseudosubstrate is bound to the kinase domain. The A134D aPKC is Arg-C 
sensitive, consistent with its increased activity. The AADAA mutation removes 
the protease cleavage site, confirming that cleavage does not occur at other sites 
under the conditions used. Deletion of the C1 exposes the pseudosubstrate 
indicating that the C1 functions, at least in part, to displace the pseudosubstrate.  
C. Lgl cortical localization assay for aPKC activity. Lgl localizes to the cortex of 
cultured S2 cells (first column) even when co-expressed with aPKC (aPKC WT) 
or a kinase dead mutant (aPKC K293W), but becomes displaced into the 
cytoplasm with expressed with an aPKC pseudosubstrate mutant (aPKC 
RRDRR). Arrowheads indicate cortical Lgl signal.  
D.  Quantification of Lgl localization in S2 cells. The percentage of cells with 
cortical or cytoplasmic Lgl is shown when expressed by itself or with the aPKC 




Par-6 activates aPKC 
 Our observation that aPKC is autoinhibited is inconsistent with the current model in 
which Par-6 inhibits aPKC activity. The lack of detectable kinase activity for full-length 
aPKC under our assay conditions suggests that further in ibition is unlikely to be 
physiologically relevant. Thus, we decided to revisit the role of Par-6 in aPKC 
regulation. Previous studies used bacterially expressed Par-6 to investigate its effect on 
aPKC activity. However, we noticed that bacterially prepared Par-6 is highly 
aggregated (Fig. 7A), presumably because of its PB1 domain as the CRIB-PDZ 
fragment is soluble and monomeric. Thus, previously observed aPKC repression may 
have been due to non-specific effects of the aggregated protein. To overcome this 
problem, we co-expressed Par-6 with aPKC in HEK293 cells and purified them together 
as a complex. When prepared in this manner, Par-6 and aPKC form a discrete complex 
as assessed by gel filtration chromatography (Fig. 7B), and with high purity as shown 
by SDS-PAGE (Fig. 7C).  
To determine the effect of Par-6 on aPKC activity, we first compared the activity 
of the co-purified aPKC/Par-6 complex to that of aPKC alone. Par-6 and aPKC interact 
via their PB1 domains (50), and Par-6 also contains semi-CRIB and PDZ domains (106) 
(Fig. 8A).  Rather than lowering the activity of aPKC, we found that Par-6/aPKC activity 
is significantly higher than aPKC alone, comparable to the activity of the aPKC 
pseudosubstrate mutants (Fig. 8B). This effect is due, in part, to the Par-6 PB1 domain as 
this domain alone is sufficient to activate aPKC (Fig. 8C). The PB1 does not activate to 
the same level as full-length Par-6, however, indicating that the CRIB-PDZ domain does 




PB1-PB1 interactions, and possibly additional interactions elsewhere among the two 
proteins.
 
Figure 7. Purification of the Par-6/aPKC complex.  
 
A. Bacterially expressed Par-6 is highly aggregated. Gel filtration chromatogram of 
purified bacterially expressed Par-6. Marks represent elution volume of standard 
proteins (F, ferritin–440 kDa; C, conalbumin–75 kDa; CA, carbonic anhydrase–
29 kDa; R, RNAse A–13.7 kDa).  
B. Par-6/aPKC form a discrete complex. Gel filtration chromatogram of Par-6/aPKC 
purified from HEK293 cells. Marks represent elution volume of standard proteins 
as in panel A.  
C. Purity of the Par-6/aPKC complex as assessed by gel electrophoresis and 
coomassie brilliant blue staining.  
 
How does Par-6 activate aPKC? To determine if activtion occurs through the 
pseudosubstrate, we measured the activity of Par-6 in complex with aPKC containing 
activating pseudosubstrate mutants (Fig. 8D). We observed that this complex has activity 
similar to the Par-6 complex with wild-type aPKC suggesting that Par-6 acts through the 
pseudosubstrate to increase aPKC activity. We verified the effect on the pseudosubstrate 
by assessing the Arg-C sensitivity of the Par-6/aPKC complex (Fig. 8E). As opposed to 
aPKC alone, the pseudosubstrate in the Par-6/aPKC complex is readily digested by Arg-
C. The pseudosubstrate is also accessible to Arg-C in the Par-6 PB1 complex with aPKC, 
but to a lesser degree, consistent with the lower activity of this complex. We conclude 




We also tested whether Par-6 activates aPKC in a cellular context using the Lgl 
cortical localization assay in S2 cells (Figs. 8F,G). While aPKC alone is unable to 
displace Lgl into the cortex, co-expression of Par-6 or just its PB1 domain led to 
cytoplasmic Lgl, consistent with our in vitro observations. Thus, measurements i  vitro 
and in cells indicate that Par-6 activates aPKC catalytic activity rather than repressing it.  
 
Figure 8 (next page). Par-6 activates, and Baz represses aPKC. 
 
A. Par-6 domain structure and interactions.  
B. Par-6 increases the catalytic activity of aPKC. Theactivity of full-length aPKC is 
shown for comparison.  
C. The Par-6 PB1 domain is sufficient for aPKC activation. The activities of full-
length aPKC and Par-6 activated aPKC are shown for comparison.  
D. Mutation of the pseudosubstrate does not increase aPKC activity when bound to 
Par-6. A mutation that inactivates the pseudosubtrate (“AADAA”), thereby 
activating aPKC (see Fig. 1G), has no effect in the Par-6/aPKC complex. The 
activities of full-length aPKC and Par-6 activated aPKC are shown for 
comparison.  
E. The aPKC pseudosubstrate is protease sensitive when aPKC is bound to full-
length Par-6 or its PB1 domain (see Fig. 1G for comparison to wild-type aPKC). 
F. Co-expression of Par-6 or its PB1 domain with aPKC causes cortical 
displacement of Lgl in S2 cells. Lgl (red signal) associates with the S2 cell cortex 
but phosphorylation by aPKC (green) causes displacement into the cytoplasm. 
Although aPKC itself has no effect on Lgl localizaton (Fig. 2C), co-expression 
with Par-6 (blue) leads to cytoplasmic Lgl.  
G. Quantification of the Lgl localization data shown in panel F for 50 cells. H, 
Bazooka (Baz) inhibits aPKC phosphorylation of the Lgl peptide. Addition of the 
Baz aPKC Binding Region (ABR) causes a decrease in the extent of Lgl that is 









In addition to Par-6, the “Par complex” also includes Baz. As Baz is an aPKC 
substrate, it may compete with phosphorylation of other substrates like Lgl, although Baz 




we examined the effect of the Baz aPKC binding region (ABR; Baz residues 905-1221) 
on Lgl phosphorylation by Par-6/aPKC (Fig. 8H). Addition of Baz dramatically 
decreased the extent of Lgl peptide phosphorylation.  
 
Lgl is efficiently phosphorylated and released from the Par-6/aPKC complex 
 In Drosophila SOP cells, Lgl is thought to remain in a complex with aPKC until 
Aurora A activity phosphorylates Par-6, activating the complex (85). A key prediction of 
this model is that Lgl is a stable member of a ternary complex with Par-6 and aPKC, even 
though Lgl is an aPKC substrate. Our work above used a small peptide from Lgl that is 
phosphorylated by the complex and it is possible that full-length Lgl represses aPKC 
activity and remains associated with Par-6/aPKC. We examined if Par-6/aPKC 
phosphorylated full-length Lgl in vitro and observed significant phosphorylation, 
although somewhat less than with the Lgl peptide (Fig. 9A). We also tested whether Lgl 
is a stable part of the Par complex using a Maltose Binding Protein (MBP) fused Lgl 
adsorbed onto amylose resin. This protein efficiently pulls down Par-6/aPKC in the 
absence of ATP, but addition of ATP abolished the int raction (Fig. 9B). The result of 
this interaction assay indicates that MBP-Lgl is released from Par-6/aPKC once it is 
phosphorylated, as expected for an enzyme’s substrate, suggesting that Lgl transiently 










Figure 9. Lgl is a transient component of the Par complex.  
 
A. Full-length Lgl is phosphorylated by the Par-6/aPKC complex. Comparison of the 
relative phosphorylation of Lgl full-length and the Lgl peptide (see Fig. 1A).   
B. Phosphorylated Lgl is released from the complex. Although MBP-Lgl efficiently 
pulls down aPKC in the absence of ATP, the addition of ATP causes release of 
the enzyme, such that it is no longer pulled-down.  
C. Model for autoinhibited aPKC. The C1 and pseudosubstrate synergistically 
repress the aPKC catalytic domain. D, Model for Par-6 activated aPKC. The 
interaction of the Par-6 PB1 with aPKC causes releas  of the pseudosubstrate 





 Although aPKC activity is required for many cell polarities, excess activity can lead 
to tissue disorganization and overproliferation. Thus, a central question in cell polarity is 
how aPKC catalytic activity is kept in an appropriate range during dynamic processes 
such as asymmetric cell division. In the current study, we investigated the interplay 
between elements within aPKC and protein-protein interactions with Par-6 in regulating 
catalytic activity. We used both an in vitro reconstitution strategy along with a cultured 
cell cortical displacement assay to measure aPKC activity under a wide variety of 
contexts. Our observations indicate that aPKC is strongly autoinhibited and that 




Dual domain autoinhibition of the aPKC kinase domain 
 We observed that aPKC is strongly autoinhibited. Although the full-length protein 
has detectable activity, it is significantly less active than the isolated kinase domain. For 
example, at 10 µM of substrate, the kinase domain is approximately 50-fold more active 
than full length aPKC. We focused on three NH2-terminal domains as candidates for 
autoinhibition. The PB1 domain that binds the Par complex member Par-6 by PB1 
heterodimerization is not required for autoinhibition. Surprisingly, however, aPKC 
autoinhibition is brought about by collaboration of the two other domains, the kinase 
interacting pseudosubstrate and the C1 domain. The aPKC pseudosubstrate efficiently 
interacts with the kinase domain and is readily phos rylated when the decoy alanine is 
replaced with a phosphorylatable residue. Activation of aPKC by mutation of key kinase-
interacting residues leads to exposure of the pseudosubstrate, as detected by protease 
sensitivity. Pseudosubstrate exposure and kinase activation also occur when the C1 
domain is deleted indicating that it plays a previously unappreciated role in regulating 
kinase activity through the pseudosubstrate. In a recent structure of canonical PKC (107), 
the C1 domain makes contacts with the kinase domain suggesting that it could make 
contacts that provide additional stabilization of the pseudosubstrate interaction. 
 
Allosteric activation of aPKC by Par-6 
 Although the aPKC PB1 domain isn’t required for autoinhibition, its interaction 
with the Par-6 PB1 leads to activation. Par-6 activtion of aPKC doesn’t lead to full 
activity, as the kinase domain alone is still significantly more active. However, the ability 




activity may be sufficient for physiological function. Par-6 activation appears to occur 
through an allosteric mechanism in which the key inhibitory pseudosubstrate interaction 
is displaced. How might Par-6 binding influence pseudosubstrate interaction with the 
kinase domain? Based on the close proximity of the PB1 and pseudosubstrate in the 
aPKC sequence, we propose a steric model in which PB1-PB1 interaction is incompatible 
with aPKC autoinhibition (Figs. 9C,D). In this model the pseudosubstrate occupies the 
kinase active site and is assisted by C1 interactions with the kinase domain. Recent work 
on the mammalian form of aPKC also implicates the C1 in regulation (108), although to a 
greater extent than described here. In canonical PKCs the C1 domain couples 
diacylglycerol binding to activation by binding to the kinase N-lobe (106,107). In aPKC, 
activation instead occurs by binding to the PB1 domain which lies on the opposite side of 
the pseudosubstrate (Fig. 5A).  
 
Par-6 couples aPKC localization and activation 
 How is aPKC regulated during complex polarization processes such as asymmetric 
cell division? Current models include Par-6 repression of aPKC as a core component but 
our results suggest that these models should be reexamined. How might aPKC 
autoinhibition and activation by Par-6 regulate polarity? In Drosophila neuroblasts and 
SOP cells, aPKC is cytoplasmic early in the cell cycle but becomes polarized to the 
cortex by metaphase. Localization of aPKC occurs by interactions with Par-6, suggesting 
that this early, unlocalized pool of aPKC may not be bound to Par-6 and therefore, 
autoinhibited. By metaphase, Par-6 becomes polarized to the cortex where it can recruit 




substrate phosphorylation only occurs at the correct pla e and time. 
 How do other Par complex regulatory components influe ce activity? The 
substrates Lgl and Baz have been proposed to regulat  aPKC–Lgl by inhibiting and Baz 
by activating catalytic activity. We have found that Lgl behaves as a typical kinase 
substrate, only transiently associating with the enzyme. Baz also acts as a substrate, 
competing for the active site with other substrates such as Lgl. In SOP cells, Lgl is 
localized uniformly to the cortex early in the cell cycle but ultimately becomes polarized 
to a domain opposite to aPKC before being completely displaced into the cytoplasm. This 
dynamic pattern of localization correlates well with low aPKC activity early in the cell 
cycle (due to autoinhibition) followed by polarized activation from interactions with Par-
6. Baz, on the other hand, remains localized in the same cortical domain with Par-6 and 
aPKC (although it localizes to a separate region in epithelia cells). Further work, both in 
vitro and in vivo, is required to understand how the constellation of pr teins that interact 
with Par-6 and aPKC regulate catalytic activity and cellular function.  
 
BRIDGE TO CHAPTER III 
 In this chapter, I have demonstrated how intra- and intermolecular interactions 
work synergistically to regulate aPKC activity and localization. In a polarized cell, aPKC 
activity outputs as exclusion of aPKC substrates from the cortex. How does 
phosphorylation result in displacement of substrate molecules? One of the observations is 
that Mira, Lgl, and Numb all contain multiple phosphorylation sites. However, it is 
unclear if multi-site phosphorylation is involved in the regulation of displacement 




multiple locations. In the following chapter, I describe how multi-site phosphorylation 
plays a vital role in substrate release from the membrane using Lgl as a model substrate 
in cultured Drosophila S2 cells. Finally, I investigate how aPKC preferentially 
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 Many cells organize their cortical regions into large, molecularly discrete 
domains. The resulting cell polarity is essential for a broad array of processes, including 
cytokinesis, movement, and asymmetric division (86,87). The atypical Protein Kinase C 
(aPKC), part of the Par polarity complex, has emerged as a key organizer of the cell 
cortex (31,37,109). In Par-mediated polarity, upstream components specify the location 
and activity of aPKC. Once at the cortex, aPKC phosrylates substrates, displacing 
them into the cytoplasm, thereby ensuring that theyonl  occupy cortical regions opposite 
aPKC (37,91,110). Because a key aspect of Par polarity is phosphorylation coupled 
cortical displacement, we have investigated the detailed kinetics of aPKC substrate 




 The Par complex directs polarity in diverse systems using a mechanism that relies 
on aPKC-mediated phosphorylation. Besides aPKC, the Par complex consists of Par-3 
(Bazooka in flies) and Par-6. These proteins, along with a large number of upstream 
regulators, control aPKC localization and kinase activity in cells ranging from epithelia to 
neural stem cells. When not bound to Par-6, aPKC exists in an autoinhibited form with an 
internal pseudosubstrate motif bound to its kinase domain (111). Recruitment to the 
cortex by Par-3 and Par-6 activates aPKC such that it c n efficiently phosphorylate target 
proteins, such as the tumor suppressor Lethal giantlarvae (Lgl) and the fate determinants 
Numb and Miranda. Once phosphorylated, these substrate  become cytoplasmic, 
effectively displacing them from cortical regions containing aPKC. In the absence of 
aPKC catalytic activity, these substrates become depolarized with severe physiological 
consequences (43-45).  
 As substrate phosphorylation by aPKC appears to bea central element of polarity, 
we have investigated the detailed kinetics of the process. Many aPKC substrates contain 
numerous phosphorylation sites (e.g. 3 sites for Lgl (44), 5 sites for Mira (43), and 5 sites 
for Numb (45)) and non-phosphorylatable mutants are not polarized by aPKC. These 
studies suggest that multi-site phosphorylation is an important component of aPKC 
phosphorylation, although this hypothesis has not been tested. Is phosphorylation at all 
sites required for cortical displacement? Are the kin tic parameters for aPKC 
phosphorylation the same at each site? Is there synrg  between phosphorylation at each 
site?  
 Here, we investigated the role of the multiple phosphorylation using Lgl as a 




cortical displacement of Lgl using cultured Drosophila S2 cells. We find that Lgl requires 
at least two, possibly three, phosphorylations for membrane displacement. Also, we 
examined how aPKC phosphorylates Lgl at three Ser residues using in vitro kinase 
assays. We find that the three Ser sites are not kie ically equivalent, for aPKC shows a 
clear preference among them. Furthermore, we utilized phospho-mimetic mutants to test 
whether or not multi-phosphorylation is dependent. We find that it is dependent but the 
effects depend on the position of the phospho-mimetic mutation(s). We conclude that 
phosphorylation of Lgl at multiple sites by aPKC plays a vital role in regulation of Lgl 
localization. Our results may be extended to the otr aPKC substrates and differentiation 
factors to understand the mechanism of polarization. Our findings could also provide new 
insight to the substrate recognition and preference of aPKC.  
 
MATERIALS AND METHODS 
 
S2 Lgl cortical localization assay 
 Immunofluorescence was as previously described (100). Briefly, For S2 cell 
expression, aPKC was expressed using transient transfection with a modified pMT vector 
containing the Drosophila tubulin promoter in place of the metallothionen promoter. 
mCherry:Lgl coding sequences were cloned into the regular pMT vector using 5’-BglII 
and 3’-XhoI sites. Drosophila Schneider (S2) cells were maintained in Schneider's 
Medium with 10% FBS at room temperature. ~2x106 cells were seeded per well in a 6-
well plate and transfected with 0.5 µg of each construct using Effectene transfection 




and induced with 0.5 mM CuSO4 for 24h, 200µL of cells were seeded on 12 mm 
diameter glass coverslips in a 24-well plate and allowed to adhere for 1h. Cells were 
fixed for 20 minutes with 4% formaldehyde in PBS followed by 3 rinses of wash buffer 
(0.1% saponin in PBS) and two rinses of block buffer (0.1% saponin and 1% BSA in 
PBS). Coverslips were incubated overnight at 4oC with rabbit anti-aPKC  antibody 
(1:1000; Santa Cruz Biotechnology). Coverslips were then rinsed 3x with blocking 
buffer, incubated at room temperature for 2h with species-specific secondary antibodies 
(1:200; Jackson Immunoresearch), rinsed 3x in washing buffer, and mounted in 
Vectashield Hardset Mounting Medium (Vector Laboraties). Images were acquired on 
a confocal microscope (Radiance; Biorad laboratories) using an oil-immersion 60x 
1.4NA objective, processed with ImageJ, and assembled in Adobe Illustrator. 
 
Purification of aPKC 259-606 (Kinase Domain) 
 HEK293 F cells (1X106 cells/mL) were transfected with pCMV His6-aPKC 259-
606 and pCMV dPDK-1 (without any tag) using the 293fectin transfection reagent (Life 
Technology). The cells were incubated at 37 °C for 48 hours. To harvest, the cells  were 
resuspended with Ni2+ lysis buffer (50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 1 mM 
MgCl, 10 mM β-ME, 10 mM Imidazole, adjusted to pH 7.5 with NaOH). Then, the cells 
were lysed open using syringes and 21-gauge needles and the whole cell lysate was 
centrifugation at 15,000 rpm for 30 min. at 4 °C.  The supernatant was incubated with 
Ni2+ NTA resins for 45 min at 4 °C. The resins were washed with the lysis buffer. The 
proteins were eluted using Ni2+ elution buffer (50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 




eluted proteins were dialyzed at 4 °C for 4 hours. The concentration of aPKC was 
determined by comparing its reactivity with an anti-aPKC antibody (Santa Cruz Biotech) 
with that of a standard of known concentration (bacterially expressed aPKC kinase 
domain purified and quantified using a Bradford dyebinding assay) on a western blot.  
 
Expression and purification of Lgl peptides 
 The esidues 647-673 of Drosophila Lgl isoform A were cloned into pMAL-C2 
vector (New England BioLabs Inc.), in which a TEV protease recognition site was added 
following the MBP coding sequence. The residues S656, S660, and S660 in Lgl 647-673 
were mutated to alanines or aspartic acids. The constructs were transformed into BL21 E.
coli cells. The expressions were induced by 0.4 mM IPTG at 18 °C overnight. The 
bacterial lysates were incubated with amylose resins (New England BioLabs Inc.). The 
resins were washed with MBP lysis buffer (20 mM Tris-HCl pH 7.5, 200 mM NaCl, 1 
mM EDTA, 1 mM DTT). The MBP-fusion proteins were eluted with MBP elution buffer 
(20 mM TrisHCl pH 7.5, 200 mM NaCl, 1 mM EDTA, 1 mM DTT, 5 mM altose) and 
dialyzed at 4 °C  overnight in 20mM TrisHCl pH7.5, 50mM NaCl, 1 mM DTT.  
 
In vitro kinase activity assay 
 aPKC kinase activity was measured as previously described (98). Briefly, the 
purified aPKC kinase domain was diluted to concentrations at which the incorporation of 
radiolabeled phosphate from [γ-32P]ATP into MBP-Lgl peptides were linear with respect 
to time and the enzyme concentrations. The diluted enzymes were preincubated in the 




of MBP-Lgl peptide concentrations at 30 °C for 5 min. The reactions were initiated by 
adding 1mM ATP spiked with [γ-32P]ATP (~1.0 x 106/nmol ATP). The reactions were 
incubated at 30 °C for 10 min. The reaction mixtures were blotted on Grade P81 
phosphopaper (Whatman). The reactions were quenched by immediately submerging the 
blotted P81 paper in 75 mM H3PO4. 5mL of scintillation fluid were added to measure th
radioactive decays by liquid scintillation counter. 
 
Kinetic modeling 
 Copasi was used to model the phosphorylation reaction of wild type Lgl. To 
investigate if phosphorylations are cooperative, we us d measured KM and Vmax values of 
SAA, ASA, and AAS for the first phosphorylation, SDA, SAD, ASD, DSA, ADS, and 
DAS for the second phosphorylation, and SDD, DSD, and DDS for the third 
phosphorylation. The phosphorylations were plotted over time.  
 
Separation of single-, double-, and triple-phosphorylated Lgl peptides 
 A reaction containing 15 µM MBP-Lgl  647-673, aPKC kinase domain, 1 mM 
ATP in the reaction buffer described above was set up and incubated at 30 °C for 90 min. 
Small aliquots of the reaction mixture were quenched with SDS-PAGE loading buffer 
periodically during the incubation. The quenched samples were run on Mn2+- Phos-tag 
SDS-PAGE (Wako USA). The phosphorylated Lgl was detect d on western blot using 
mouse anti-MBP (1:1000; Santa Cruz Biotechnology) and bovine anti-mouse HRP 







Lgl cortical displacement requires phosphorylation at multiple serines  
 aPKC phosphorylates Lgl at three serine residues in vitro, and non-
phosphorylatable Lgl fails to be released from the plasma membrane when expressed in 
neuroblasts. Non-phosphorylatable Lgl also causes th  fate determinant Miranda to 
become depolarized (44). These data indicate that phosphorylation plays a crucial role in 
Lgl localization and function. However, the role of Lgl’s multiple phosphorylation sites is 
unknown. 
To determine the role of individual Lgl phosphorylation events in its localization, 
we mutated the phosphorylatable serine residues to alanine in all possible combinations 
(Fig. 10A). The resulting proteins were tested for their localization in cultured 
Drosophila S2 cells, which have been utilized previously to investigate the membrane 
localization of aPKC substrates including Lgl. Wild type Lgl localizes at the plasma 
membrane when expressed alone, and in the cytoplasm when co-expressed with active 
aPKC. When there is only one Ser residue available for aPKC to phosphorylate, Lgl 
remained at the cortex regardless of the position of the phosphosite (fig. 10B). The 
comparison of cytoplasmic/cortical intensity ratios showed that the mutants are not 
significantly different from Lgl alone (p < 0.01) (Fig. 10C), suggesting that a single 
phosphorylation is not sufficient to release Lgl from the membrane.   
 While one phosphorylation does not lead to a detectable effect on Lgl’s 
localization, Lgl mostly localized in the cytoplasm when two of the three serine residues 




localization was still distinguishable from phosphorylated wild type Lgl as the 
cortical/cytoplasmic ratio for the two phosphorylation site Lgls are statistically different 
from both Lgl alone and Lgl with aPKC (Fig. 10C). Our data showed the general trend of 
increased cytoplasmic localization and reduced cortical/cytoplasmic intensity ratio, as the 
number of the available phosphorylation sites increased. These data suggest that Lgl 
needs to be phosphorylated at all three phosphorylation sites to be completely displaced 
from the membrane.  
Figure 10 (next page). Lgl requires multiple phosphorylation for cortical displacement.  
 
A. Lgl domain structure and aPKC phosphosite positions. Localization assays used 
full length Lgl whereas the kinetic assays were performed with maltose-binding 
protein-fused Lgl residues 647-673.The localization of mCherry-Lgl mutants in 
cultured Drsophila S2 cells. The localization assays show the more 
phosphorylatable, the more cytoplasmic Lgl localizes.  
B. The localization of mCherry-Lgl wild-type and aPKC phosphosite mutants in 
cultured Drsophila S2 cells.  
C. Quantification of Lgl cortical localization (n = 50 for each condition). ANOVA 
statistical analysis reveals that cortical recruitment of wild-type Lgl is 
indistinguishable from singly-phosphorylated Lgl (SAA, ASA, and AAS), and 
Lgl variants with two phosphorylatable sites (ASS, AS, and SSA) are 










aPKC preferentially phosphorylates Lgl at Ser656 and Ser664 
 The localization assays demonstrated the necessity of multiple phosphorylation 
for Lgl displacement. Thus, intrinsic kinetic differences between the three sites could be 
very important for Lgl localization and function. However, it was unclear whether aPKC 
would preferentially phosphorylate the serine residues or if each of the three sites are 
equivalent. Compared to the consensus sequence (Fig. 11A), the amino acid sequence 
alignment surrounding the phosphorylation sites for each Lgl peptide shows that all 
peptides satisfy the requirement at P-5, P-2, and P+1 positions while they all fail to match 
at P-4 and P+2 positions. Also, there are more variations at N-terminal residues away 
from each phosphorylation sites. Therefore, comparison of each of the Lgl subsite 
sequences with the consensus sequence suggests that aPKC could have different kinetic 
parameters for each of the three sites. 
 
Figure 11 (next page). Non-equivalent phosphorylation of the three Lgl phosphosites by 
aPKC.  
 
A. . Amino acid sequence alignment of Lgl phosphorylation sites. The phopho-
accepting serines (P0) are labeled with red asterisks. The optimal consensus 
sequence is shown at the bottom (112). Note that multiple residues are accepted in 
some positions.  
B. Kinetic analyses of each singly-phosphorylated Lgl peptide, showing differences 
in KM and kcat.  
C. The possible pathways to phosphorylate all three phos osites. Phosphorylated 
residues are highlighted with red. If the phosphorylation events are independent, 
based on the results from b, preferential phosphorylation occurs in the order of 









To determine whether the three serine residues are equivalent or not, we 
generated singly-phoshorylatable Lgl peptides and performed the kinase assays. Using 
Michaelis-Menten analyses, we determined the catalytic efficiency (kcat/KM) for 
phosphorylation at each subsite. As Fig. 11B shows, KM values for each serine were 7.8 
µM, 11.4 µM, and 3.8 µM and kcat values were 3.18 sec
-1, 1.48 sec-1, and 4.29 sec-1 for 
SAA, ASA, and ASA, respectively. The catalytic efficiency values were 0.407 µM -1 sec-
1, 0.130 µM -1 sec-1, and 1.141 µM -1 sec-1, respectively. There are six possible pathways 
to phosphorylate all three Lgl serine residues (Fig. 11C) and, if the sites were 
independent, our data indicate a preferential order of Ser664 > Ser656 > Ser660.  
 
aPKC phosphorylation of Lgl is cooperative 
 As each serine residue in Lgl is only separated by three residues, it is likely that 
phosphorylation events interact with one another and phosphorylation at one site could 
influence the kinetic parameters of others (i.e. cooperativity). To investigate whether Lgl 
phosphorylation by aPKC is cooperative, we utilized phospho-mimetic mutants of Lgl 
peptides and tested them in kinase activity assays.  
 First, we tested how phosphorylation of a serine residue affects phosphorylation 
of directly neighboring sites (Fig. 12A). The values of KM for SDA, DSA, ASD, and 
ADS were 14.4 µM, 5.9 µM, 7.9 µM, and 6.2 µM and kcat were 3.31 sec
-1, 1.82 sec-1, 0.69 
sec-1, and 4.82 sec-1, respectively. The catalytic efficiencies were 0.23 µM -1 sec-1, 0.31 
µM -1 sec-1, 0.09 µM -1 sec-1, and 0.77 µM -1 sec-1, respectively. Compared to SAA, SDA 
showed 50 % reduction in the catalytic efficiency. The reduction was attributed by KM 




the replacement of Ser656 to an Asp residue increased kcat and the catalytic efficiency 
while the replacement at Ser664 decreased both values. Finally, ADS showed an increase 
in KM value, reducing phosphorylation rate compared to AAS. These data indicate that 
prior phosphorylations on the direct neighboring sites reduce the phosphorylation rates of 
Ser656 and Ser664. In contrast, the presence of the Asp residue at the adjacent site had 
favorable effect for Ser660, which may indicate that the negative charges may be needed 
for its efficient phosphorylation.  
 We next examined how a phosphate group influences the non-directly 
neighboring site using SAD and DAS peptides (Fig. 12B). Initial rate analyses showed 
that KM values were 27.37 µM and 3.73 µM and the values for kcat were 4.41 sec
-1 and 
3.38 sec-1, respectively. The catalytic efficiencies were 0.16 µM -1 sec-1 and 0.91 µM -1 
sec-1. The effect of the Asp residue at P+8 was more pronounced than at P+4 for Ser656, 
for KM value SDA was 2 times higher than SAA and the effect on kcat was minimal while 
KM value of SAD was 3 times higher and kcat was 40 % higher than SAA. For DAS, on 
the other hand, the effect was more subtle, in which kcat was reduced from AAS by 20 % 
and almost no change in KM. Combined together, the data show that phosphomimetic  
 
Figure 12 (next page). Phosphorylation events are cooperative.  
 
A-C.  Phosphorylation rates of individual Lgl sites are affected by the 
phosphorylation state of neighboring sites (as assessed by phosphomimetic 
residues). Panel (a) shows the effect of modification at directly neighboring sites, 
while panel (b) shows the effect of more distant modifications. Finally, (c) 
demonstrates the effect of modification at both of the other sites. The data show -
the phosphorylation rates are cooperative but the affects differ depending on the 
positions of the phospho-accepting residue and modified site(s). Based on the 











residue at P+8 influenced kcat, but it changed KM at P+4. These data indicate that 
proximal phosphorylation at P-8 or P+8 reduces catalytic efficiency.  
 We next examined how a phosphate group influences the non-directly 
neighboring site using SAD and DAS peptides (Fig. 12B). Initial rate analyses showed 
that KM values were 27.37 µM and 3.73 µM and the values for kcat were 4.41 sec
-1 and 
3.38 sec-1, respectively. The catalytic efficiencies were 0.16 µM -1 sec-1 and 0.91 µM -1 
sec-1. The effect of the Asp residue at P+8 was more pronounced than at P+4 for Ser656, 
for KM value SDA was 2 times higher than SAA and the effect on kcat was minimal while 
KM value of SAD was 3 times higher and kcat was 40 % higher than SAA. For DAS, on 
the other hand, the effect was more subtle, in which kcat was reduced from AAS by 20 % 
and almost no change in KM. Combined together, the data show that phosphomimetic 
residue at P+8 influenced kcat, but it changed KM at P+4. These data indicate that 
proximal phosphorylation at P-8 or P+8 reduces catalytic efficiency.  
 Finally, we examined how two phosphate groups affect the phosphorylation of the 
remaining Ser residues using SDD, DSD, and DDS Lgl peptides (Fig. 12C). The values 
of KM were 26.37 µM, 2.47 µM, and 6.40 µM and kcat were 2.04 sec
-1, 0.54 sec-1, and 
2.54 sec-1, respectively. The catalytic efficiencies were 0.08 µM -1 sec-1, 0.22 µM -1 sec-1, 
and 0.40 µM -1 sec-1, respectively. These data show that the presence of two Asp residues 
decrease the phosphorylation rates of Ser656 and Ser664 while they increase that of Ser660. 
These results indicate that Ser660 is more likely to be phosphorylated after Ser656 and 
Ser664 are phosphorylated.  
 All the kinetic parameters measured showed that the replacement of Ser660 to Asp 
residues resulted in increased KM values for Ser




presence of phosphomimetic residue(s) were beneficial to Ser660. Taken together, the 
primary order of phosphorylation is likely to be Ser664 -> Ser660 -> Ser656 while the 
secondary pathway may be Ser656 -> Ser664 -> Ser660.    
 
Ordered phosphorylations of aPKC 
 Considering how similar the sequences of the three Lgl phosphorylation subsites 
are, it was surprising how aPKC presented clear preferences among them. We reasoned 
that the residues which all three subsites failed to satisfy the consensus sequence 
requirement may not contribute much in the activity d fferences observed, and that the 
preferential phosphorylation of Ser664 originated from the differences in the residues 
surrounding Ser664 and Ser660.  
 To investigate the basis for the subsites preference within Lgl, we examined series 
of mutations in the context of Lgl ASA (Fig. 13A). First, we noticed that ASA peptide 
had a Glu residue at P+3 position while SAA and AAS peptides had a Lys at the same 
position. The values of KM and kcat for ASA E663K mutant were 12.39 µM and 1.68 µM
 -
1 sec-1, respectively, indicating that the replacement of Glu to Lys at P+3 does not 
increase the rate of ASA phosphorylation. We also te ted ASA L661F mutant. Although 
ASA mutant satisfies the hydrophobic residue requirement at P+1 position, both SAA 
and AAS peptides had a Phe residue. The values for KM and kcat for ASA L661F were 
10.66 µM and 2.47 µM -1 sec-1, respectively, suggesting that the substitution of Lue to 
Phe at P+1 position did not affect KM but kcat increased by 66%, compared to ASA. When 
ASA L661F E663K double-mutant was tested, kcat value was 1.70 µM
 -1 sec-1 and 




than ASA and 2 times lower than AAS, implying that the those two residues may play 
roles in binding affinity.  
 We followed the concentration of singly, doubly, and triply phosphorylated Lgl to 
determine how well the kinetic parameters from each site could predict bulk 
phosphorylation behavior. Using SDS-PAGE gels containing Mn2+ and Phos-tag, we 
were able to resolve each of the phosphorylated species (Fig. 13B). We then quantified 
the degree of phosphorylation and compared to a simulation of wild type Lgl 




 Phosphorylation coupled release of aPKC substrates from the plasma membrane 
is a central element of Par-mediated polarization. The mechanism by which substrates are 
released from cortex has been unclear, however. In the case of the tumor suppressor Lgl, 
phosphorylation by aPKC is crucial for not only asymmetric cell division but also 
epithelial cell polarity and cell migration (103). In the present work, we have found that  
Figure 13 (next page). Ordered phosphorylations of aPKC 
 
A. Critical recognition positions that determine the KM for aPKC phosphorylation. 
Mutation of L661F and E663K together converted KM of ASA peptide to that of 
AAS peptide. Phosphorylation of Lgl peptide with three serines. 15 mM of wild 
type Lgl peptide was phosphorylated for 90 min in the presence of aPKC kinase 
domain and 1 mM ATP. The phosphorylated Lgl was separated on Mn2+ Phos-
tag SDS-PAGE.  
B. Time course of wild-type Lgl phosphorylation as determined by phospho-
resolving gel electrophoresis. 
C. Modeling of Lgl phosphorylation by aPKC. The degree of phosphorylation was 
quantified using the data from panel (B) and overlaid with a simulation of wild 












aPKC phosphorylation of Lgl at each of its three phosphosites is required for full 
displacement from the cortex in a cultured S2 cell model system. Because multi-site 
phosphorylation is essential for cortical release, nd therefore polarization, we 
investigated the kinetics at each site, and how phos rylation at one site influences 
others. A mathematical model for Lgl phosphorylation based on the empirical parameters 
we measured is in good agreement with the overall rates of Lgl phosphorylation that we 
observed.  
 
Multi-site phosphorylation is coupled to cortical release of Lgl 
 We first addressed the relationship between the number of phosphorylations and 
cortical localization of Lgl by expressing various Lgl constructs in cultured Drosophila 
S2 cells. We observed a general trend of increasing cytoplasmic Lgl with increasing 
phosphorylation states, indicating an additive effect of multi-site phosphorylation on 
membrane interaction. Similar behavior has been observed with another aPKC substrate, 
myristoylated-alanine rich C-kinase substrate (MARCKS). Phosphorylation of three 
serine residues in MARCKS reduces its electrostatic at raction for the membrane, 
resulting in translocation of MARCKS into the cytoplasm (113-115). Multi-site 
phosphorylation of aPKC substrates could be a general mechanism for altering the 
electrostatic charges of the substrates to regulate their membrane interactions in cell. It is 
of interest to determine whether multi-site phosphorylation exhibits the same effects on 






Phosphorylation order as regulatory element for cortical displacement 
 We examined whether phosphorylation of each serine residues were equivalent 
and found that aPKC preferentially phosphorylates Lgl in the order of Ser664 > Ser656 > 
Ser660, indicating that the phosphosites are not equivalent. We also tested if phosphosites 
interact with one another and found that the effects of phosphorylation (using 
phosphomimetic residues as a proxy) depend on their pos tion relative to the target serine. 
For example, the presence of Asp at Ser656 increases KM of adjacent sites. On the other 
hand, the phosphmimetic residue(s) decreased KM for Ser
660. Our data indicate the 
primary pathway for Lgl phosphorylation is Ser664 → Ser660 → Ser656 while the 
secondary pathway is Ser656 → Ser664 → Ser660. The addition of phosphate groups on 
substrates in an ordered manner may serve as another layer of regulation in cortical 
displacement, as differences in kinetic parameters could contribute to how well fate 
determinants interact with the plasma membrane (i.e. the association and dissociation 
rates). Kinetic analyses of other aPKC substrates, combined with localization assays, will 
be useful for more generalized understanding of the relationship between the number of 
phosphorylation and cortical release behaviors.   
 
Flexibility in aPKC substrate recognition sequence 
 Substrate recognition is an important aspect of substrate binding and specificity.  
Though the three serine residues and the surrounding amino acid sequences are similar to 
one another, aPKC showed a clear preference among them, suggesting that the subtle 
difference in sequence could have a large impact on kinetic parameters and substrate 




amino acid sequence of aPKC substrates (73,104,112). All Lgl peptides satisfied the 
requirement at P-5, P-2, and P+1 positions while they all failed to match at P-4 and P+2 
positions. Our data demonstrate that the mutation of Leu to Phe at the P+1 position 
slightly increased Vmax, suggesting that the larger hydrophobic residue interacts more 
favorably with the kinase interaction surface. In co trast, mutation of Glu to Lys at the 
P+3 site, thought to be critical for recognition, did not influence the phosphorylation rate 
at Ser660. Taken together, our study suggests that the collective properties of the phospho-
accepting residue regions plays a key role in preferential binding and efficient catalysis. 
This could explain the range of amino acid requirements seen in a single recognition site. 
Our study emphasizes the complexity of substrate specificity and the flexibility of 
aPKC’s substrate recognition mechanism.  
 
BRIDGE TO CHAPTER IV 
 The data presented in Chapter III demonstrated how Lgl phosphorylation at 
multiple serine residues plays a crucial role in corti al displacement. The kinetic analyses 
show that aPKC preferentially phosphorylates Lgl although the amino acid sequences 
surrounding the phospho-accepting serine are quite similar. Also, the phosphomimetic 
mutants indicate that phosphorylation events are cooperative. These findings could 
provide new insights to the role of phosphorylation in cortical release of aPKC substrates. 
In the next chapter, I summarize my thesis research nd discuss some of the interesting 








CONCLUSIONS AND FUTURE CONSIDERATIONS 
 
CONCLUSIONS  
 Complex signaling networks are employed in cells to temporally and spatially 
regulate the catalytic activity of protein kinases, a  dysfunctional kinase cascades often 
lead to devastating diseases such as cancers. aPKC is a well-conserved regulator of cell 
polarity in metazoan systems. Unregulated phosphorylation activity of aPKC causes 
defects in development and tissue homeostasis, sugge tin  that aPKC plays crucial roles 
in the grand scheme of cell polarization. Despite its physiological significance, little is 
known about the regulatory mechanism of aPKC.  
 In Chapter II, I described both intra- and intermolecular regulation of aPKC 
activity. Previously, it was thought that aPKC was constitutively active though it 
contained a pseudosubstrate domain, whose function was reported to inhibit kinase 
activities in other kinases. To challenge the existing model, I developed a reconstituted 
system and more stringent kinetic method. With the new methods, I was able to 
determine that full length aPKC’s catalytic activity was autoinhibited by the cis-acting 
pseudosubstrate domain. Consistent with the kinetic data, Arg-C proteinase sensitivity 
assay also showed that full length aPKC was in an in ct ve conformation. Additionally, 
as S2 localization assay showed that the pseudosubstrate mutant, but not full length 
aPKC, displaced Lgl from the cortex. The above findings led me to reinvestigate the role 




repressed aPKC activity, but it seemed unnecessary to repress already inactive aPKC. To 
our surprise, the kinetic analyses and the Arg-C proteinase assays showed that Par-6 
activated aPKC by displacing pseudosubstrate domain. Co sistent with activation, Lgl 
was released from the membrane when both aPKC and Pr-6 were co-expressed. Taken 
together, our data suggest a dual role of Par-6 in aPKC polarization and aPKC activity.  
In other words, aPKC activity is coupled to localizt on via Par-6.  
 In Chapter III, I discussed how the activity of aPKC translates to the localization 
patterns of its substrates. I realized that fate derminants such as Lgl, Mira, and Numb 
contained multiple aPKC phosphorylation sites. However, it has never been directly 
tested if multi-site phosphorylations are necessary for their localization behaviors. Using 
Lgl as a model substrate in S2 localization assay, I found that Lgl localized at the cortex 
in the absence of aPKC. As the number of phosphorylations of Lgl increased, the 
cytoplasmic localization of Lgl increased. As the singly phosphorylatable Lgl was not 
statistically different from non-phosphorylated Lgl, our data suggest that multiple 
phosphorylation is required for displacement of Lglfrom the membrane. We also 
performed kinetic analyses to examine how aPKC phosrylated three serine residues in 
Lgl. Despite similarities among the residues surrounding the phospho-accepting serine 
residues, aPKC exhibited clear preferences among them. Finally, I tested whether the 
presence of negative charge(s) on the neighboring site(s) affect the preceding 
phosphorylation events. The results of phosphomimetic mutant Lgls showed that the 
phosphorylation is cooperative although the effects depended on the position of the 




possible general mechanism of cortical displacement where rates of substrate 
phosphorylation could regulate how long it would associate with the membrane.  
 My thesis research depicts how both cis- and trans-acting regulatory elements 
regulate aPKC activity and localization. My research also shows how aPKC activity is 
coupled to substrate localizations. These findings provide deeper understanding of how 
the Par complex mediates the establishment of cellular polarization.  
 
FUTURE CONSIDERATIONS 
 The data presented in Chapter II show that Par-6 PB1 was sufficient to partially 
displace pseudosubstrate domain and activate aPKC activity. However, the kinetic data 
suggest that the C-terminal part of Par-6 (CRIB-PDZ) also participate in the regulation of 
aPKC, as Par-6 PB1cannot fully recover the activity level of aPKC/Par-6 wild type 
complex. To examine the involvement of Par-6 CRIB-PDZ in aPKC regulation, we first 
tested the direct interaction between the two proteins using GST pull down assays using 
bacterially expressed GST-fused Par-6 CRIB-PDZ. The binding assay showed that wild 
type aPKC interacted with both full length Par-6 wt and Par-6 CRIB-PDZ, though CRIB-
PDZ binding was weaker than wt (Fig. 14A). Because aPKC contains PDZ ligand at the 
very distal end of the catalytic domain, it is likey that they interact each other in PDZ-
PDZ ligand mediated manner. Next, we tested the kintic effect of this interaction in the 
kinase assay. To do so, we first investigated the activity of aPKC mutant lacking PDZ 
ligand (aPKC ∆PDZL) was comparable to aPKC wild type. Then, we purified aPKC 
∆PDZL in complex with ful length Par-6. The mutant complex showed higher activity 




PDZ/CRIB-PDZ interaction regulates aPKC activity (Fig. 14B). We also purified aPKC 
∆PDZL/Par-6 PB1 complex and tested in the kinase assay. Interestingly, the activity of 
this complex was equivalent to full length aPKC, suggesting that displacement of 
pseudosubstrate domain by Par-6 PB1 requires the ineraction between PDZ-PDZ ligand. 
The exact mechanism remains to be tested.  
 In the literature, it has been reported that a Rhofamily GTPase Cdc42 is an 
upstream of aPKC that apically localizes in neuroblasts when bound to GTP (94,116). It 
is also shown to interact with Par-6 via CRIB-PDZ when it is in GTP bound form (117). 
This interaction rescues aPKC activity from Par-6 repression in vitro though the recovery 
was marginal (93). Now that we think Par-6 is an activ tor of aPKC, the role of Cdc42 is 
unclear. One possibility is that Cdc42 may be another component that couples the 
localization to the activity of aPKC as Cdc42 localizes at the apical cortex prior to Par-6. 
It is also possible that Cdc42 further activates aPKC activity in the context of aPKC/Par-
6, as the activity of the complex is about 50 % of aPKC kinase domain alone. 
 In Chapter III, I used Lgl as a model substrate to xamine how multiple 
phosphorylation plays a role in its localization and how aPKC preferentially 
phosphorylates those sites. It is possible that the addition of the multiple phosphates may 
attenuate the interaction with the plasma membrane as the electrostatic charges of 
substrate change (113,114). To examine if this is a general mechanism that other aPKC 
substrate utilizes, this hypothesis needs to be test d with other proteins such as Mira and 
Numb. It would be also beneficial to compare if thephosphorylation rate differences 
among the substrates correlates to how long they remain bound to the membrane. It 






Figure 14. Par-6 CRIB-PDZ participates in regulation of aPKC activity.  
A. GST pulldown assay to test the direct interaction between aPKC wt and Par-6 
130-255 (CRIB-PDZ). Bacterially expressed GST-fusion Par-6 and GST-Par-6 
CRIB-PDZ were immobilized onto glutathione-agarose. Then, aPKC wt was 
allowed to interact with GST-fusion proteins. The interaction was examined by a 
western blot probing against aPKC with rabbit anti-PKC antibody.  
B. The effects of aPKC PDZ ligand on its aPKC catalytic activity. Deletion of PDZ 
ligand from aPKC (aPKC ∆PDZL) did not affect the enzyme activity and the 
mutant showed the similar activity level with full length aPKC alone. aPKC 
∆PDZL in complex with Par-6 wt exhibits partial activation compared to full 
length alone. But it was less than that of aPKC/Par-6 PB1 complex. aPKC 






artificially engineered substrate whose number of phos ho-accepting serines and 
phosphorylation rates are modulated.  
 
CONCLUDING REMARKS 
 As our understanding of signal transduction increases, it is clear that multiple 
layers of complex regulatory mechanisms precisely control localization and activity of 
protein kinases. My research shows that aPKC is no exception to this general 
phenomenon. Here, I have described the intricate but legant intra- and intermolecular 
mechanisms responsible for the regulation aPKC. Additionally, I have also depicted that 
aPKC phosphorylation activity outputs as displacement of its substrate from the plasma 
membrane. These results demonstrate a seemingly simple strategy of cells where activity 
and localizations of the enzyme as well as its substrates are coupled one another. These 
















SUPPLEMENTAL MATERIALS FOR CHAPTER II 
 
Abbreviations used in this chapter:  
 
GST  Glutathione-S-transferase 
MBP  Maltose-binding protein 
 
 
Supplemental figure 1. Characterization of aPKC proteins used in this study. 
 
A. Purity as assessed by SDS-PAGE and coomassie brilliant blue staining. The band 
corresponding to wild type aPKC (as identified by reactivity with the anti-aPKC 
antibody) is marked with an arrowhead. 
B. Activation loop phosphorylation. Upper panel shows western signal using an 
antibody specific to aPKC containing a phosphorylated activation loop. The lower 
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